Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - David C . Mulligan, M.D.

Back to Research Profile

  1. Mulligan D. Living donor liver transplantation and donor graft size: How small can we go to reduce risk to the donor and what is the cost to the recipient? Liver Transpl 2009 Oct 28; 15(11):1392-1394. [Epub ahead of print]
    View PubMed
  2. Jaroszewski DE, Pierce CC, Staley LL, Wong R, Scott RR, Steidley EE, Gopalan RS, DeValeria P, Lanza L, Mulligan D, Arabia FA. Simultaneous heart and kidney transplantation after bridging with the CardioWest total artificial heart. Ann Thorac Surg 2009 Oct; 88(4):1324-6.
    View PubMed
  3. Jaroszewski DE, Pierce CC, Staley LL, Wong R, Scott RR, Steidley EE, Gopalan RS, Devaleria P, Lanza L, Mulligan D, Arabia FA. Simultaneous Heart and Kidney Transplantation After Bridging With The CardioWest Total Artificial Heart. AnnThorac Surg 2009 Oct; 88(4):1324-6.
    View PubMed
  4. Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MMI, D'Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GBG. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009 Sep; 9(9):2004-11.
    View PubMed
  5. Mekeel KL, Moss AA, Mulligan DC, Chakkera HA, Hamawi K, Mazur MJ, Heilman RL, Reddy KS. Deceased donor kidney transplantation from donors with acute renal failure due to rhabdomyolysis. Am J Transplant 2009 Jul; 9(7):1666-70. Epub 2009 May 20.
    View PubMed
  6. Chakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, Hamawi K, Mulligan DC, Moss AA, Mekeel KL, Cosio FG, Cook CB. Hyperglycemia during the immediate period after kidney transplantation. Clin J Am Soc Nephrol 2009 Apr; 4(4):853-9. Epub 2009 Apr 01.
    View PubMed
  7. Mekeel K, Moss A, Reddy KS, Douglas D, Mulligan D. Sclerosing peritonitis and mortality after liver transplantation. Liver Transpl 2009 Apr; 15(4):435-9.
    View PubMed
  8. Li F, Mekeel KL, Eleid M, Harrison ME, Reddy KS, Moss AA, Mulligan DC. Hemobilia and pancreatitis after liver transplant biopsy. Liver Transpl 2009 Mar; 15(3):350-1.
    View PubMed
  9. Heilman RL, Chakkera H, Mazur M, Petrides S, Moss A, Mekeel K, Mulligan D, Reddy KS. Outcomes of simultaneous kidney-pancreas transplantation with positive cross-match. Transplant Proc 2009 Jan-Feb; 41(1):303-6.
    View PubMed
  10. Hastings D, Patel B, Torloni AS, Mookadam F, Betcher J, Moss A, Heilman R, Mazur M, Hamawi K, Mulligan D, Reddy K, Mekeel K, Chakkera H. Plasmapheresis therapy for rare but potentially fatal reaction to rituximab. J Clin Apher 2009; 24(1):28-31.
    View PubMed
  11. Ko EY, Castle EP, Desai PJ, Moss AA, Reddy KS, Mekeel KL, Mulligan DC, Andrews PE. Utility of the endovascular stapler for right-sided laparoscopic donor nephrectomy: a 7-year experience at Mayo Clinic. J Am Coll Surg 2008 Dec; 207(6):896-903. Epub 2008 Aug 30.
    View PubMed
  12. Ko EY, Castle EP, Desai PJ, Moss AA, Reddy KS, Mekeel KL, Mulligan DC, Andrews PE. Utility of the endovascular stapler for right-sided laparoscopic donor nephrectomy: a 7-year experience at Mayo Clinic. J Am Coll Surg 2008 Dec; 207(6):896-903.
    View PubMed
  13. Mekeel KL, Moss AA, Reddy KS, Mulligan DC, Harold KL. Laparoscopic fenestration of giant hepatic cysts. Surg Laparosc Endosc Percutan Tech 2008 Oct; 18(5):511-3.
    View PubMed
  14. Mekeel KL, Moss AA, Reddy KS, Douglas DD, Vargas HE, Carey EJ, Byrne TJ, Harrison ME, Rakela J, Mulligan DC. Living donor liver transplantation in polycystic liver disease. Liver Transpl 2008 May; 14(5):680-3.
    View PubMed
  15. Heilman RL, Chakkera HA, Reddy KS, Colby TV, Moss AA, Williams JW, Mazur MJ, Petrides S, Mulligan DC. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression. Clin Transplant 2008 May-Jun; 22(3):309-15.
    View PubMed
  16. Mekeel K, Mulligan D, Reddy KS, Moss A, Harold K. Laparoscopic incisional hernia repair after liver transplantation. Liver Transpl 2007 Nov; 13(11):1576-81.
    View PubMed
  17. Mekeel KL, Mazur MJ, Reddy KS, Mulligan DC, Heilman RL, Chakkera HA, Andrews PE, Moss AA. Diffuse parenchymal urine leak after kidney transplantation following degloving injury during donor nephrectomy. Am J Transplant 2007 Aug; 7(8):2039-41. Epub 2007 Jun 18.
    View PubMed
  18. Pasha SF, Harrison ME, Das A, Nguyen CC, Vargas HE, Balan V, Byrne TJ, Douglas DD, Mulligan DC. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc 2007 Jul; 66(1):44-51.
    View PubMed
  19. Sachdev MS, Blair JE, Mulligan DC, Kusne S. Coccidioidomycosis masked by symptoms of end-stage liver disease in transplant candidates. Transpl Infect Dis 2007 Jun; 9(2):153-5.
    View PubMed
  20. Cheruvattath R, Balan V, Stewart R, Heilman RL, Mulligan DC, Kusne S. Kluyvera co-infection in two solid organ transplant recipients: an emerging pathogen or a colonizer bystander? Transpl Infect Dis 2007 Mar; 9(1):83-6.
    View PubMed
  21. Blair JE, Mulligan DC. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transpl Infect Dis 2007 Mar; 9(1):78-82.
    View PubMed
  22. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl 2006 Dec; 12(12 Suppl 3):S105-7.
    View PubMed
  23. Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transpl 2006 Dec; 12(12 Suppl 3):S114-6.
    View PubMed
  24. Sharma P, Harper AM, Hernandez JL, Heffron T, Mulligan DC, Wiesner RH, Balan V. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transplant 2006 Aug; 6(8):1957-62. Epub 2006 Jun 09.
    View PubMed
  25. Heilman RL, Reddy KS, Mazur MJ, Moss AA, Post DJ, Petrides S, Mulligan DC. Acute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab. Transplant Proc 2006 Jun; 38(5):1307-13.
    View PubMed
  26. Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V. Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci 2006 Jun; 51(6):1070-8.
    View PubMed
  27. Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl 2006 Apr; 12(4):560-5.
    View PubMed
  28. Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant 2005 Sep; 5(9):2244-7.
    View PubMed
  29. Frasco PE, Poterack KA, Hentz JG, Mulligan DC. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg 2005 Jul; 101(1):30-7, table of contents.
    View PubMed
  30. Orrego M, Guo LS, Reeder C, De Petris G, Balan V, Douglas DD, Byrne T, Harrison E, Mulligan D, Rodriguez-Luna H, Moss A, Reddy K, Rakela J, Vargas HE. Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection. Liver Transpl 2005 Jul; 11(7):796-9.
    View PubMed
  31. Heilman RL, Mazur MJ, Reddy KS, Moss A, Post D, Mulligan D. Steroid avoidance immunosuppression in low-risk kidney transplant recipients. Transplant Proc 2005 May; 37(4):1785-8.
    View PubMed
  32. Faybush E, Mulligan DC, Birch BD, Sirven JI, Balan V. Liver transplant in a patient with a ventriculoperitoneal shunt. Liver Transpl 2005 Apr; 11(4):467-8.
    View PubMed
  33. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology 2004 Nov; 127(5 Suppl 1):S261-7.
    View PubMed
  34. Rodriguez-Luna H, Balan V, Sharma P, Byrne T, Mulligan D, Rakela J, Vargas HE. Hepatitis C virus infection with hepatocellular carcinoma: Not a controversial indication for liver transplantation. Transplantation 2004 Aug 27; 78(4):580-3.
    View PubMed
  35. St Peter S, Rodriquez-Davalos MI, Rodriguez-Luna HM, Harrison EM, Moss AA, Mulligan DC. Significance of proximal biliary dilatation in patients with anastomotic strictures after liver transplantation. Dig Dis Sci 2004 Aug; 49(7-8):1207-11.
    View PubMed
  36. Arenas JI, Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib A, Fasola C, Adair D, Radkowski M, Kibler KV, Nowicki M, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas HE. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J Infect Dis 2004 Jun 1; 189(11):2037-46.
    View PubMed
  37. Mulligan DC, Reddy KS, Moss AA Jr. New preservation solutions for use in liver transplantation. Current Opinion in Organ Transplantation 2004 Jun; 9(No 2):159-62.
  38. Carey EJ, Douglas DD, Balan V, Vargas HE, Byrne TJ, Moss AA, Mulligan DC. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience. Liver Transpl 2004 Apr; 10(4):529-33.
    View PubMed
  39. Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, Hansen K, Mulligan D, Moss A, Douglas DD, Balan V, Rakela J, Vargas HE. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha 2b and ribavirin: An open-label series. Transplantation 2004 Jan 27; 77(2):190-4.
    View PubMed
  40. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transpl 2004 Jan; 10(1):36-41.
    View PubMed
  41. Rodriguez-Luna H, Vargas HE, Sharma P, Ortiz J, De Petris G, Balan V, Byrne T, Moss A, Mulligan D, Rakela J, Douglas DD. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 2004 Jan; 49(1):38-41.
    View PubMed
  42. Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, Mulligan DC, Rakela J, Wiesner RH, Balan V. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl 2003 Dec; 9(12):1273-80.
    View PubMed
  43. *St Peter SD, Moss AA, Huettl EA, Leslie KO, Mulligan DC. Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma. Clin Transplant 2003 Dec; 17(6):549-53.
    View PubMed
  44. Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis 2003 Mar; 5(1):3-8.
    View PubMed
  45. St Peter SD, Moss AA, Mulligan DC. Effects of tacrolimus on ischemia-reperfusion injury. Liver Transpl 2003 Feb; 9(2):105-16.
    View PubMed
  46. St Peter SD, Post DJ, Rodriguez-Davalos MI, Douglas DD, Moss AA, Mulligan DC. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transpl 2003 Feb; 9(2):144-9.
    View PubMed
  47. Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RAF. Recent advances in liver transplantation. Mayo Clin Proc 2003 Feb; 78(2):197-210.
    View PubMed
  48. St Peter SD, Nguyen CC, Mulligan DC, Moss AA. Subcutaneous metastasis at a surgical drain site after the resection of pancreatic cancer. International Journal of Gastrointestinal Cancer 2003; 33(2-3):111-5.
    View PubMed
  49. Lefler SR, Lille ST, Huemer G, Tucker R, Murray T, Schoeller T, Mulligan DC. Activation time course of activator protein-1 and effect of proline dithiocarbamate during ischemia-reperfusion in rat skeletal muscle. Ann Plast Surg 2002 Dec; 49(6):654-9.
    View PubMed
  50. Lefler SR, St Peter SD, Rodriguez-Davalos MI, Perumean JC, Spence NA, Moss AA, Mulligan DC. Amelioration of hepatic ischemia/reperfusion injury using indolepropionic acid. Transplant Proc 2002 Dec; 34(8):3065-6.
    View PubMed
  51. Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD, Harrison ME, Mulligan DC, Olden K, Adair D, Rakela J. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 2002 Nov; 8(11):1014-9.
    View PubMed
  52. Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O'Brien PC, Spivey JR, Dickson RC, Harnois DM, Douglas DD, Hughes CB, Nguyen JH, Mulligan DC, Steers JL. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 2002 Jun 27; 73(12):1904-9.
    View PubMed
  53. Molmenti EP, Roodhouse TW, Molmenti H, Jaiswal K, Jung G, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Elliott EE, Bursac N, Mulligan D, Gonwa TA, Klintmalm GB. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg 2002 Feb;235(2):292-6.
    View PubMed
  54. Abbas MA, Collins JM, Mulligan DC. Renal cell carcinoma metastatic to pancreas. Am J Surg 2001 Aug; 182(2):183-184.
    View PubMed
  55. Mulligan DC. Resection vs. Transplantation for Hepatocellular Carcinoma. Audio-Digest Gastroenterology 2001 Jul; 15(7).
  56. Lille ST, Lefler SR, Mowlavi A, Suchy H, Boyle EM Jr, Farr AL, Su CY, Frank N, Mulligan DC. Inhibition of the initial wave of NF-kappaB activity in rat muscle reduces ischemia/reperfusion injury. Muscle & Nerve 2001 Apr; 24(4):534-41.
    View PubMed
  57. Abbas MA, Mulligan DC, Ramzan NN, Blair JE, Smilack JD, Shapiro MS, Lidner TK, Olden KW. Colonic perforation in unsuspected amebic colitis. Dig Dis Sci 2000 Sep; 45(9):1836-41.
    View PubMed
  58. Molmenti EP, Roodhouse TW, Jaiswal K, Jennings LW, Sanchez EQ, Marubashi S, Jung G, Brooks BK, Conkey A, Mulligan DC, Levy MF, Goldstein RM, Klintmalm GB. Portal vein thrombendvenectomy in cases of organized portal vein thrombosis at the time of liver transplantation. Transplantation 2000 Apr; 69(8):Suppl S, 242.
  59. Post AB, Mulligan DC, Bush W. Cost analysis of four strategies for prevention of CMV infection in liver transplant recipients. Transplant Proc 1998 Aug; 30(5):2102-3.
    View PubMed
  60. Chitale AA, Sterling RK, Post AB, Silver BJ, Mulligan DC, Schulak JA. Resolution of spur cell anemia with liver transplantation: a case report and review of the literature. Transplantation 1998 Apr 15; 65(7):993-5.
    View PubMed
  61. Fabia R, Levy M, Crippin J, Weldon T, Aguanno J, Dysert P, Mulligan DC, Holmberg S, Goldstein R, Husberg B, Gonwa T, Klintmalm G. Novo Hepatitis B Infection After Liver Transplantation: Source of Disease, Incidence, and Impact. Liver Transpl Surg 1998; 4:119-27.
    View PubMed
  62. Harwell CM, Newman LN, Cacho CP, Mulligan DC, Schulak JA, Friedlander MA. Abdominal catastrophe: visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis. Perit Dial Int 1997 Nov-Dec; 17(6):586-94.
    View PubMed
  63. Ghandour FZ, Knauss TC, Mulligan DC, Schulak JA, Hricik DE. Influence of steroid withdrawal on proteinuria in renal allograft recipients. Clin Transplant 1997 Oct; 11(5 Pt 1):395-8.
    View PubMed
  64. Schulak JA, Mulligan DC, Robinson A. Intrathymic spleen cell inoculation and ALS fails to induce tolerance to rat pancreas allografts. Transplant Proc 1997 Feb-Mar; 29(1-2):1070-1.
    View PubMed
  65. Schulak J, May E, Post A, Fasola C, Mulligan D, Sterling R. Reduction of early rejection in adult liver transplantation with ATG induction therapy. Transplant Proc 1997 Feb-Mar; 29(1-2):555-6.
    View PubMed
  66. Mulligan D, Gentry L, Dombrausky L, Klintmalm G, Nikaein A. Monitoring of allograft recipients for the development of HLA-specific antibodies: elimination of OKT3 as a complicating factor. Clin Transplant 1995 Dec; 9(6):438-41.
    View PubMed
  67. Mulligan DC, Klintmalm GB. Should liver transplantation be performed for hepatitis B? Clin Transplant 1995 Jun; 9(3 Pt 2):246-8.
    View PubMed
  68. Levy MF, Jennings L, Abouljoud MS, Mulligan DC, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Quality of life improvements at one, two, and five years after liver transplantation. Transplantation 1995 Feb 27; 59(4):515-8.
    View PubMed
  69. Mulligan DC, Goldstein RM, Crippin JS, Abouljoud MS, Levy MF, Husberg BS, Gonwa TA, Foster BR, Tillery GW, Klintmalm GB. Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc 1995 Feb; 27(1):1204-5.
    View PubMed
  70. Abouljoud MS, Levy MF, Rees CR, Diamond NG, Lee SP, Mulligan DC, Goldstein RM, Husberg B, Gonwa TA, Klintmalm GB. A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation. Transplantation 1995 Jan 27; 59(2):226-9.
    View PubMed
  71. Holmberg S, Levy M, Goldstein R, Husberg B, Mulligan DC, Gonwa T, Brooks B, Jennings L, Klintmalm G. Lymphoma after liver transplantation - a single center clinical and epidemiological experience. Swedish Journal of Medicine 1994.
  72. Mulligan DC, McHenry CR, Kinney W, Esselstyn CB. Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy. Surgery 1993 Dec; 114(6):1114-9.
    View PubMed
  73. Levy MF, Goldstein RM, Husberg BS, Gonwa TA, Backman L, Abouljoud M, Mulligan D, Klintmalm GB. Baylor update: outcome analysis in liver transplantation. Clin Transpl 1993; 161-73.


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.